T1	Participants 482 669	a total of 56,294 men aged 55-74 years were screened with serum prostate specific antigen (PSA) in five countries of the European Randomised Study of Screening for Prostate Cancer (ERSPC)
T2	Participants 1336 1347	Netherlands
T3	Participants 1354 1372	Sweden and Finland
T4	Participants 1379 1384	Italy
T5	Participants 1394 1401	Belgium
